CRH Q2 revenue rises 6% to $10.8 billion; net income up 13%; guidance reaffirmed
CRH reported second quarter 2026 results with total revenues of $10.8 billion, up 6% from the prior year, and net income of $1.5 billion, up 13%. The company reaffirmed its full-year 2026 guidance for net income, Adjusted EBITDA and diluted EPS, and said it has not started a new share buyback tranche while the $8.5 billion Arcosa acquisition is pending.
Key points
- Q2 2026 diluted EPS was $2.21, up from $1.94 in Q2 2025; Adjusted EBITDA was $2.6 billion, up 7%.
- Q2 net income included gains on divestitures; income tax expense rose to $661 million from $425 million.
- 2026 guidance reaffirmed: net income $3.9 billion to $4.1 billion, Adjusted EBITDA $8.1 billion to $8.5 billion, diluted EPS $5.60 to $6.05.
- Capital expenditure guidance was lowered to $2.7 billion to $2.9 billion from $2.8 billion to $3.0 billion; no new buyback tranche has started since the Arcosa agreement on June 22, 2026.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.